Skip to main content
OpenTrials

Clinical trial condition

OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma

Explore clinical trials studying OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma trial results

Recruiting

Clinical Study of OR for Second-line Treatment of Refractory MZL

NCT06134284

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • The Second Affiliated Hospital of Zhejiang University, Ningbo First Hospital Hangzhou, Zhejiang, China
  • 86-574-87085596 Ningbo, Zhejiang, China
  • The First Affiliated Hospital of Ningbo University Ningbo, Zhejiang, China
View Trial Details

Related conditions